Загрузка начнется через 5 секунды. Если загрузка не началась автоматически нажмите ссылку ниже.
Vitamin C: attenuating effect on growth and proliferation in systemic malignancies
Received: January 25, 2013
Correspondence: E-mail: email@example.com
The recent article by J. Cha et al. provided for highly interesting reading .Vitamin C may attenuate tumor growth in a number of other systemic malignancies.
Vitamin C has a negative impact on tumor growth in breast cancers. Similarly it mitigates tumor metastasis. It mediates this effect in part by attenuating IL-6 levels . Similar effect is seen on VEGF levels. Interestingly, intravenous ascorbic acid has been shown to significantly improve the quality of life in breast cancer survivors during chemotherapy . For instance, symptoms such as depression and nausea are markedly decreased. Enhanced anti-proliferative effects are seen when vitamin C is administered in conjunction with agents such as retinoic acid . In one recent study, the reported synergistic ratio of retinoic acid and vitamin C was 1.72. Vitamin C also augments the anti-neoplastic activity of chemotherapeutic agents such as cisplatin . Similarly it increases the sentivity of breast cancer cells to agents such as doxorubicin.
Similar effects are seen in gastric malignancies. Vitamin C tends to augment intra-tumoral apoptosis. It mediates this effect by down-regulating 14–3–3σ via a mitochondrial dependent pathway . Part of these pro-apoptotic effects are also mediated via p38-MAP kinase-dependent up-regulation of transferrin receptor . It also increases the Bax/ Bcl-xL ratio. These effects are dose dependent. Administration of vitamin C also augments superoxide dismutase activity. Vitamin C also enhances MHC class I expression by the cancerous cells . At the same time Fas (CD95) expression is markedly augmented. As a result the sensitivity of cancer cells to anti-Fas antibodies is significantly accentuated.
Similarly, decreased RBC vitamin C levels have been noted in patients with prostate carcinomas. In fact, recent studies indicate that vitamin C markedly attenuates tumor growth in hormone refractory prostatic malignancies . It also has a negative impact on tumor metastasis. Part of these effects are mediated via VEGF inhibition. At the same time vitamin C has an inhibitory effect on MMP-9 .
The above examples clearly highlight the significant anti-neoplastic effects of vitamin C.
1. Cha J, Roomi MW, Ivanov V, et al. Ascorbate depletion increases growth and metastasis of melanoma cells in vitamin C deficient mice. Exp Oncol 2011; 33: 226–230.
No Comments » Add comments